These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 11554061)

  • 1. [Recent advances of clinical and basic research in rapidly progressive glomerulonephritis].
    Yamagata K; Koyama A
    Nihon Rinsho; 2001 Sep; 59(9):1837-46. PubMed ID: 11554061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Case of scleroderma with rapid progressive glomerulonephritis associated with both MPO-ANCA and anti-GBM antibodies].
    Namba T; Hatanaka M; Takahashi A; Takeji M; Takahara K; Uzu T; Yamauchi A
    Nihon Jinzo Gakkai Shi; 2008; 50(1):64-8. PubMed ID: 18318246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apheresis for MPO-ANCA-associated RPGN-indications and efficacy: lessons learned from Japan nationwide survey of RPGN.
    Yamagata K; Hirayama K; Mase K; Yamaguchi N; Kobayashi M; Takahashi H; Koyama A
    J Clin Apher; 2005 Dec; 20(4):244-51. PubMed ID: 15880406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Rapidly progressive glomerulonephritis associated with myeloperoxidase specific-antineutrophil cytoplasmic antibody in patients with rheumatoid arthritis : report of three cases].
    Yoshihara R; Tanaka Y; Shiozawa K; Hayakawa M; Nagao M; Imura S
    Ryumachi; 1996 Oct; 36(5):762-8. PubMed ID: 8969556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of glomerular diseases: ANCA-negative RPGN.
    Bolton WK
    Semin Nephrol; 2000 May; 20(3):244-55. PubMed ID: 10855934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Rapid-detection GBM-ANCA ELISA. An emergency tool for the early diagnosis of type I and II rapidly progressive glomerulonephritis].
    Arranz O; Ara J; Rodríguez R; Poveda R; Serra A; Solé-Amigó J; Fort J; Mirapeix E; Darnell A
    Nefrologia; 2001; 21(4):349-54. PubMed ID: 11816510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvements in treatment strategies for patients with antineutrophil cytoplasmic antibody-associated rapidly progressive glomerulonephritis.
    Hotta O; Ishida A; Kimura T; Taguma Y
    Ther Apher Dial; 2006 Oct; 10(5):390-5. PubMed ID: 17096692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A case of myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA) related glomerulonephritis associated with systemic sclerosis treated by steroid pulse therapy: a case report].
    Mizutani A; Tanaka I; Katayama M; Oshima H; Komatsu Y; Asano S; Kato K; Matsumura H; Ishii K; Miyama H; Nagai T; Kato K; Fukaya S; Yoshida S; Hasegawa M; Kawashima S; Torikai K
    Ryumachi; 2000 Oct; 40(5):828-32. PubMed ID: 11215162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ANCA-associated crescentic glomerulonephritis with mesangial IgA deposits.
    Haas M; Jafri J; Bartosh SM; Karp SL; Adler SG; Meehan SM
    Am J Kidney Dis; 2000 Oct; 36(4):709-18. PubMed ID: 11007672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The relationships of rapidly progressive glomerulonephritis (RPGN), crescentic glomerulonephritis and vasculitis: the clinical, histopathological and therapeutic considerations].
    Covic A; Marian D; Florea L; Mititiuc I; Căruntu I; Cotuţiu C; Covic M
    Rev Med Chir Soc Med Nat Iasi; 1996; 100(3-4):63-72. PubMed ID: 9455438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Neutrophil anticytoplasmic antibodies: their diagnostic utility in vasculitis and glomerulonephritis].
    Bosch X; Mirapeix E; Font J; López-Soto A; Rodríguez R; Vivancos J; Revert L; Ingelmo M; Urbano-Márquez A
    Med Clin (Barc); 1994 Mar; 102(11):412-7. PubMed ID: 8182997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myeloperoxidase anti-neutrophil cytoplasmic autoantibodies (MPO-ANCA)-related rapidly progressive glomerulonephritis (RPGN) and pulmonary fibrosis (PF) with dissociated evolution.
    Souid M; Terki NH; Nochy D; Hillion D
    Clin Nephrol; 2001 Apr; 55(4):337-8. PubMed ID: 11334325
    [No Abstract]   [Full Text] [Related]  

  • 13. Rapidly progressive glomerulonephritis: current and evolving treatment strategies.
    Little MA; Pusey CD
    J Nephrol; 2004; 17 Suppl 8():S10-9. PubMed ID: 15599880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment with cytapheresis for antineutrophil cytoplasmic antibody-associated renal vasculitis and its effect on anti-inflammatory factors.
    Hasegawa M; Watanabe A; Takahashi H; Takahashi K; Kasugai M; Kawamura N; Kushimoto H; Murakami K; Tomita M; Nabeshima K; Oohashi A; Kondou F; Ooshima H; Hiki Y; Sugiyama S
    Ther Apher Dial; 2005 Aug; 9(4):297-302. PubMed ID: 16076370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Present status and future perspective of RPGN in Japan].
    Usui J; Yamagata K
    Nihon Jinzo Gakkai Shi; 2009; 51(2):78-83. PubMed ID: 19378790
    [No Abstract]   [Full Text] [Related]  

  • 16. [Epidemiology of rapidly progressive glomerulonephritis (RPGN) and ANCA-associated vasculitis].
    Fujimoto S
    Nihon Jinzo Gakkai Shi; 2009; 51(2):84-7. PubMed ID: 19378791
    [No Abstract]   [Full Text] [Related]  

  • 17. Anti-neutrophil cytoplasmic antibodies and effector CD4+ cells play nonredundant roles in anti-myeloperoxidase crescentic glomerulonephritis.
    Ruth AJ; Kitching AR; Kwan RY; Odobasic D; Ooi JD; Timoshanko JR; Hickey MJ; Holdsworth SR
    J Am Soc Nephrol; 2006 Jul; 17(7):1940-9. PubMed ID: 16769746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MPO-ANCA-associated pulmonary-renal vasculitis in a patient with diabetes mellitus.
    Keven K; Akar H; Kutlay S; Nergizoglu G; Erbay B; Erturk S
    J Nephrol; 2002; 15(6):720-3. PubMed ID: 12495292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ANCA-associated crescentic IgA glomerulonephritis in pregnancy.
    Amir AR; Sheikh SS
    J Nephrol; 2002; 15(6):716-9. PubMed ID: 12495291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Four cases of anti-myeloperoxidase antibody-related rapidly progressive glomerulonephritis during the course of idiopathic pulmonary fibrosis.
    Hiromura K; Nojima Y; Kitahara T; Ueki K; Maezawa A; Kawai H; Yano S; Naruse T
    Clin Nephrol; 2000 May; 53(5):384-9. PubMed ID: 11305812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.